Iverson Shawn M, Spierer Oriel, Papachristou George C, Feuer William J, Shi Wei, Greenfield David S, O'Brien Terrence P
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 7101 Fairway Drive, Palm Beach Gardens, FL, 33418, USA.
Ophthalmology Division, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Int Ophthalmol. 2018 Feb;38(1):223-231. doi: 10.1007/s10792-017-0451-4. Epub 2017 Mar 16.
To compare corneal graft survival rates after penetrating keratoplasty (PK) and Descemet's stripping endothelial keratoplasty (DSEK) in patients with a glaucoma drainage device (GDD) or medically managed glaucoma.
A retrospective chart review was conducted on consecutive patients who underwent primary PK or primary DSEK. Inclusion criteria consisted of eyes with a diagnosis of glaucoma prior to corneal transplantation and a minimum of 6 months of follow-up. Graft failure was defined as an edematous cornea with failure to maintain deturgescence lasting beyond a period of 1 month of intense steroid therapy or vascularization and scarring resulting in irreversible loss of central graft clarity. Corneal graft survival was calculated using Kaplan-Meier survival analysis. Patients were divided into four groups: GDD-PK, GDD-DSEK, medical-PK and medical-DSEK.
Fifty-six eyes of 56 patients were identified as meeting inclusion criteria. Among eyes with a GDD, there was no difference in the proportion of failures between PK grafts (48%) and DSEK grafts (50%) (p = 0.90). Failure occurred earlier in DSEK recipients compared to PK recipients, 5.82 ± 6.77 months versus 14.40 ± 7.70 months, respectively (p = 0.04). A Kaplan-Meier analysis did not identify a difference between the four groups with respect to graft failure (p = 0.52).
There is no significant difference in graft survival rates between medically and surgically treated glaucoma patients for either PK or DSEK grafts. In patients with GDD, graft failure occurs earlier in DSEK compared to PK.
比较穿透性角膜移植术(PK)和Descemet膜剥脱内皮角膜移植术(DSEK)在植入青光眼引流装置(GDD)或药物治疗青光眼患者中的角膜移植存活率。
对连续接受初次PK或初次DSEK的患者进行回顾性病历审查。纳入标准包括角膜移植术前诊断为青光眼且至少随访6个月的眼睛。移植失败定义为角膜水肿,在强化类固醇治疗1个月后仍未能维持消肿,或血管化和瘢痕形成导致中央移植片清晰度不可逆转丧失。使用Kaplan-Meier生存分析计算角膜移植存活率。患者分为四组:GDD-PK、GDD-DSEK、药物-PK和药物-DSEK。
56例患者的56只眼被确定符合纳入标准。在植入GDD的眼中,PK移植片(48%)和DSEK移植片(50%)的失败比例无差异(p = 0.90)。与PK受者相比,DSEK受者的失败发生更早,分别为5.82±6.77个月和14.40±7.70个月(p = 0.04)。Kaplan-Meier分析未发现四组在移植失败方面存在差异(p = 0.52)。
对于PK或DSEK移植片,药物治疗和手术治疗的青光眼患者的移植存活率无显著差异。在植入GDD的患者中,DSEK的移植失败比PK更早发生。